Annual report pursuant to Section 13 and 15(d)

Subsequent Events (Details)

v3.22.1
Subsequent Events (Details) - USD ($)
 1 Months Ended 12 Months Ended
Mar. 02, 2022
Feb. 28, 2022
Jan. 20, 2022
Mar. 25, 2022
Dec. 31, 2021
Dec. 31, 2020
Subsequent Event [Line Items]            
Proceeds from pre-funded warrant exercises         $ 11,800 $ 0
Pre-funded Warrants            
Subsequent Event [Line Items]            
Warrants exercise (in shares)         11,800,000 48,533,334
Intrinsic value of warrant exercises         $ 460,200 $ 2,104,667
Proceeds from pre-funded warrant exercises         $ 11,800  
Subsequent Event            
Subsequent Event [Line Items]            
Common stock issued for services (in shares) 150,000          
Subsequent Event | VivaCell | Exclusive Sponsored Research Agreement            
Subsequent Event [Line Items]            
Budget committed       $ 190,000    
Subsequent Event | Brother Of CEO | Consulting Agreement            
Subsequent Event [Line Items]            
Annual rate per hour   $ 75        
Termination notice period   15 days        
Subsequent Event | Pre-funded Warrants            
Subsequent Event [Line Items]            
Warrants exercise (in shares)     19,666,667      
Intrinsic value of warrant exercises     $ 1,178,033      
Proceeds from pre-funded warrant exercises     $ 1,967